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THE  HISTORY  OF  G-6-PD  DEFICIENCY 
E.  Beutler 
City of Hope  National Medical  Center 
Duarte,  California,  U.S.A. 
The  discovery of glucose-6-phosphate dehydrogenase  (G-6-PD)  deficiency 
was  the outgrowth of studies of drug-induced hemolytic  anemia.  In 1926 it 
was  found  that the  new  6-methoxy-8-aminoquinoline antimalarial,  primaquine, 
produced acute hemolytic  anemia in some  subjects.  During World  War  II pri-
maquine,  a  more  effective analog  of this compound,  was  synthesized.  This 
drug,  too,  had  the capacity to produce hemolytic  anemia.  Using cross-trans-
fusion studies with chromium  51  it was  demonstrated that  sensitivity to  the 
hemolytic effect of primaquine  was  due  to an intrinsic defect of the ery-
throcyte.  The  hemolytic  anemia  induced by  this drug was  found  to be  self-
limited,  because  only the  older members  of the red cell population were 
destroyed.  Primaquine-sensitive erythrocytes were  found  to be  sensitive 
also to a  variety of  other drugs  including certain sulfonamides and aceta-
nilid. However,  they were  not destroyed by  the administration of quinine, 
chloroquine,  and many  other  sulfonamides.  Primaquine-sensitive red cells 
displayed a  different pattern of Heinz  bodies formation than did normal 
cells when  incubated with acetylphenylhydrazine.  Inhibition of red cell me-
tabolism with arsenite and iodoacetate caused normal cells to behave  like 
primaquine-sensitive cells with respect  to Heinz  body formation.  This led 
to investigation of the glutathione  (GSH)  content  of red cells, and  the 
concentration of this tripeptide was  found  to  be  diminished.  Further  stu-
dies revealed that the  GSH  of primaquine-sensitive red cells was unstable 
when  they were  incubated with acetylphenylhydrazine,  and this finding  led 
to elucidation o£  the primary defect as G-6-PD  deficiency.  In the few 
years  subsequent to 1956,  when  the  enzyme  deficiency was  first identified, 
it was  recognized that G-6-PD  deficiency was  a  disorder with a  world-wide 
distribution. It became  apparent that in Negro  populations the enzyme  de-
ficiency was  relatively mild,  while it was  much  more  severe in Mediterra-
nean populations. Moreover,  the electrophoretic mobility of the  red cell 
enzyme  was  found  to differ in different individuals.  Study of the  genetics 
of glucose-6-phosphate dehydrogenase also led to the  development  of the 
X-inactivation hypothesis.  Glucose-6-phosphate dehydrogenase variants have 
been used for  genetic studies and in tracing the  origin of tumors. -4-
Glucose-6-phosphate  dehydrogenase  deficiency represents an example 
of a  situation in which  the  study of a  clinical disorder led to important 
basic  biologic information. -5-
G6PD  AS  A  TOOL  FOR  GENETIC  RESEARCH 
M.  Sini  scalco 
Memorial  Sloan-Kettering Cancer Center 
New  York,  N.Y.,  U.S.A. 
The  discovery that  G6PD  deficiency is the primary defect in indivi-
duals with primaquinsensitivity and/or clinical favism has  been an inva-
luable gift for  students of human  inheritance. 
Through  extensive population and  pedigree  studies it was  soon esta-
blished that the structural gene  for  this enzyme  is X-linked in all mamma-
lian species  so far  studied and highly polymorphic in humans  as well as in 
marsupials.  The  human  population studies established beyond  doubt  that at 
least  two  deficient mutants at this locus confer to their carriers a  higher 
biological fitness in malarial environment.  In populations with a  high fre-
quency of  G6PD  deficiency of mediterranean type  (such as  Sardinia,  Israel 
and  Greece) it has  been possible to use this marker  for establishing the 
linkage relationship  between the  G6PD  locus and  many  other X-linked loci 
such as those for  deutan and protan colorblindness,  Xg(a)  red-cell antigen, 
muscular distrophy of Duchenne  and  Becker  type,  X-linked ichtyosis,  ecto-
dermal dysplasia anydrotica,  hemophilia A and  B.  These  studies led to the 
discovery of  three very tight linkages:  G6PD-deutan colorblindness,  G6PD-
protan colorblindness and G6PD-hemophilia A.  The  latter one  is a  linkage of 
medical interest,  since it makes  possible  the detection of silent carriers 
of hemophilia A  (most  of the  time  impossible  to classify on  the basis of the 
sole factor VIII  deficiency)  in families which  happen to segregate for  both 
traits. Other population studies in Sardinia made  use of the  G6PD  polymor-
phism to·detect linkage disequilibrium and to estimate the frequency  of 
X-chromosome  non disjunction among  parents of  XXY~linetelter patients. 
To  date,  over a  hundred mutants have  been detected at ·the  G6PD  locus 
and  for  a  few  o£  them it has  been demonstrated that the primary structure 
o£  the mutant polypeptide chain differs £rOm  that of the wild type in terms 
of a  single aminoacid substitution.  One  of the most  valuable contributions 
of  G6PD  as a  tool for  genetic analysis has  been the demonstration that so-
matic  tissues of heterozygotes at this locus are  "mosaic",  but that clones 
of fibroblasts derived from· such  individuals exhibit only one  or  the  other 
of the  two  allelic gene  products.  The  latter finding  gave  the first unequi--6-
vocal experimental proof in favor  of  the  so-called Lyon-Russel-Beutler 
hypothesis on the random  and irreversible inactivation of the X-chromosome 
in early embryos  of normal  females as well as of individuals with multiples 
X's.  These  studies were also utilized to prove  the monoclonal  origin of 
certain tumors  by  showing  that the malignant tissues arisen in G6PD  hetero-
zygotes exhibit only one  of the  two  allelic products.  One  of the latest 
and most  rewarding applications of G6PD  as a  tool for genetic research is 
related to its use as cellular marker  in linkage and complementation stu-
dies with  somatic cell hybrids.  The  rationale for  these  studies is well 
known.  Murine  and human  somatic cells can be  fused with the help of inacti-
vated Sendai virus and/or exposure  to polyethylene glycol.  The  resulting 
hybrids undergo  the progressive and preferential loss of human  chromosomes. 
Thus,  human  genes can be  mapped  by  correlating the retention or loss of 
human  genetic markers with that of the corresponding human  chromosomes. 
Since  the X-linkage of G6PD  was  already established beyond  doubt  through 
pedigree analysis,  this marker was  the first to have  been used to demonstra-
te the X-linkage of other human  inborn errors of metabolism  (such as  HGPRT 
deficiency,  PGK  deficiency and alpha-galactosidase deficiency)  whose  X-lin-
ked pattern of inheritance was  suspected  but not definitely proven at the 
time. 
Variation in the degree  of somatic mosaicism in different tissues of 
G6PD  heterozygotes has  been used to estimate  the size of the primordial cen 
pool at the time of inactivation and  to spot  the occurrence of somatic  se-
lection in vivo. 
In turn,  somatic cell genetics has  proven to be  a  powerful  tool  to 
gather further  knowledge  on  the genetics and  biochemistry of G6PD.  For 
instance,  by using rodent human  somatic cell hybrids derived from  human 
parental cells with X-autosomal  translocations, it has  been possible to 
assign the structural locus for  G6PD  to the  subterainal region of the long 
arm  of the human  X-chromosome.  Other rodent human  hybrids derived from  the 
fusion of G6PD  aormal rodent cells with  G6PD  deficient human  cells have 
shown  the formation of normally active heteropolymeric  G6PD  molecules,  thus 
indicating the potentialities of somatic cell hybridization for  a  novel 
approach to the study of the molecular pathology of the  G6PD  molecule via 
complementation analysis. -7-
POSTTRANSLATIONAL  AL'IERATIONS  OF  NORMAL  AND  MUTANT  G6PD  MOLECULES 
A.  Kahn 
Institut de  Pathologie Moleculaire  du  C.N.R.S. 
Paris,  France 
Once  synthesized an enzymatic protein can undergo a  series  o£  modifica-
tions varying in nature and  consequences. 
Sometimes  these postsynthetic events are indispensable in the trans-
formation o£  an inactive proenzyme  into a  catalytically efficient enzyme. 
In other cases  the posttranslational modifications are mainly involved in 
the  phenomena  o£  molecular aging,  leading ultimately to inactivation and 
degradation o£  the enzyme  proteins.  The  modifications  o£  G6PD  in various 
tiss~es belong rather to the latter group,  the  enzyme  being initially syn-
thesized in a  fully active form. 
TWo  different phenomena  must  be  distinguished: 
.- a  partial proteolysis o£  the C terminal end  o£  the  enzyme,  responsi-
ble £or  the appearance  o£  the  erythrocyte  type G6PD,  and, 
.- a  likely covalent  linkage between G6PD  and  a  degradation pro-
duct  o£  the coenzyme  NADP+,  responsible £or  the  transformation into the 
"so called" hyperanodic  forms. 
The  C terminal  sequence  o£  native  G6PD  purified £rom  leukocytes  ar 
platelets is "Asp-Ala-Gly-Ser-Leu-Lys-Leu. 
In the red cells a  partial hydrolysis occurs,  at the level o£  the gly-
cine,  serine or  leucine residue.  This proteolysis o£  the C terminal end  o£ 
the enzyme  is not associated with either diminished activity or altered ki-
netics o£  G6PD. 
The  mechanisms  o£  the  second phenomenon is totally different: 
pure  glucose-6-phosphate dehydrogenase is transformed into  "hyperano-
dic forms" when  incubated at acidic pH  and in the presence  o£  NADP+  with 
excess  o£  flucose-6-phosphate  or with  some  "NADP+  modifying proteins" pu-
rified £rom  the  same  cells. 
The  enzyme  hyperanodic  forms  exhibit a  low isoelectric point,  altered 
kinetic properties and high lability to heat,  urea,  and proteolysis. Dif-
ferences  between hyperanodic  and native forms  o£  glucose-6-phosphate dehy-
drogenase are also noted by microcomplement  fixation analysis,  UV  absor--8-
in the oxidation o£  NADPH.  This can be  demonstrated in conditions of 2,3 
DPG  breakdown,  where  the pyruvate formed  serves as oxidant. 
2) Oxidative insults 
A variety o£ reactive chemical species  such as o 2H•,  o·,  H 2o 2  and 
organic radicals have  been implicated as cause of oxidative stress. Neither 
the reactive species nor  the mechanisms  of damage  or for  the defense against 
such insults have  been clarified so far.  Our  knowledge  is greatest concer-
ning the reactions removing  H 2o2,  in which  both  glutathioneperoxidase and 
catalase participate.  There  are two  misconceptions concerning  them:  a)  an 
overestimation o£  the relative importance  o£  glutathioneperoxidase,  which 
actually removes only 1/4 o£  the H 2o 2,  and  b)  an overemphasis of the peroxi-
dative reaction o£  catalase, which  accounts for only 1/10 of total catalase 
activity.  The  powerful activity of the enzymes  destroying H2o2  makes  it 
very unlikely that ~02 may  be  highly significant as damaging  agent. Although 
that  a  rise of formate concentration cannot  increase  the rate of removal 
of H202  there are nevertheless astounding effects:  the formation of Heinz 
bodies is reduced,  the maintenance of GSH  concentration is improved  and  the 
oxidative pentose phosphate pathway  is inhibited. It would  appear worth-
while  to attempt a  medication with formate  - a  harmless substance - in the 
prevention of hemolytic crises. -9-
ROLE  OF  REACTIVE  OXYGEN  DERIVATIVES  AND  RELATED  ENZYMES 
IN  THE  METABOLIC  BALANCE  OF  REDOX  IN'IERMEDIATE.S  IN  THE 
RED  BLOOD  CELL 
G.  Rotilio 
II Cattedra di  Chimica  Biologica,  Facolta di  Scienze  e  Centro 
di  Biologia Molecolare del C.N.R.,  Universita di  Roma. 
Rorna,  Italia 
Electron donation to m.olecular  oxygen is involved in several  biochemi-
cal processes in aerobic organisms,  such as energy production in  mitochon-
dria,  chemical modification of metabolites  by  oxydases and  oxygenases,  and, 
in a  wider  sense,  oxygen  transport  by respiratory proteins. In all these 
circumstances a  variety of  intermediatesof oxygen reduction are expected on 
purely chemical  grounds,  according to  the  following  simplified scheme: 
02  + 1  e  ~a;  (superoxide) 
a;+ 1  e  ~  H202  (hydrogen peroxide) 
H202  +  1  e ----+ OH  (hydroxyl radical) 
OH  + 1  e  ---t H 20  (water  ) 
Among  these derivatives H 2o is the most  stable  and unreactive,and all 
the  system is driven toward its accumulation. o;  and  H 2o 2  can be utilized 
in the cell by  oxygenases and peroxidases with eventual formation o£  more 
H20,  or are dismuted  by  superoxide dismutases and catalases,  which again 
yield H 20  as a  product. 
However  some  o£  these intermediates can react with cellular components  by 
electron abstraction,  leading to oxidative damage  o£  the cell. Aerobic  eel~ 
contain enzymes  and  scavengers to counteract these damaging reactions.  The 
balance  o£  production and disappearance  o£  reactive intermediates thus de-
pends on  both the extent  o£  their output £rom  any possible source and  the 
activity and concentration of the  defense  systems. 
In the case o£  red blood cells,  the chain o£  reactive intermediates 
outlined in the above  scheme  is likely to originate £rom  the process o£ 
oxygen  binding to Hb.  The  chain-initiating species is liberated £rom  Oxy 
Hb  (Hb++  o 2),  leaving Met  Hb  (Hb+++)  according to three possible mechanisms: 
1  )  dissociation of a; from  Hb+++  a; which is considered by many  authors to 
be  actual electronic state o£  Hb++  o2  (1); 
2)  polarization of the Hb++  o2  complex  and  subsequent displacement  o£ a; 
+++  - .  - (  )  £rom  the resulting Hb  o2  by  an~ons,  such as Cl  2  ; -10-
3)  reduction o£  Hb++  02  by various reagents  (generally referred to as 
drugs:  phenols,  nitrites,  8-aminoquiloniles,  phenylhydrazines etc.), with 
generation o£  H2o2  and subsequently o;  (3): 
Hb++o
2 
+  DH  ~  Hb+++  +  HO;  + n• 
n·  +  o2
~  D  + o; 
4)  oxidation o£ Hb++  02  by trace metals with production o£  o;  (4): 
Hb ++o
2 
+  Cu ++---+ Hb +++  +  0
2 
+  Cu + 
cu+ +  o
2 --+ eu++  + o; 
According  to these mechanisms,  H2o2  and in most cases o;  are  the 
primary derivatives arising £rom  reactions o£  Hb  o2•  Further potentially 
harmful  species are produced by  secondary reactions,  namely: 
o;  +  o;  +  2H+  ~ 1  o2  + H2 o2  (a ) 
H202  +  ~02  --+  :02  +  2H20  (b ) 
02  + H2o2 
---t  02  +  OH- +  OH•  (c  ) 
These reactions are all electron exchange reactions  between intermedia-
tes  o£  oxygen reduction and yield very powerful  oxidizing molecules  such as 
singlet oxygen  (1o2)  and hydroxyl radical  (oH•).  However  they are  slow in 
the absence  o£ catalysts. In particular reaction  (a)  requires H+  and re-
action  (b)  and  (c  )  are catalyzed by  metal  ions. At  physiological pH,  re-
action  (a  )  is relatively slow and it is likely that in the erythrocyte all 
o; would enter either reaction  (c  )  since metal catalysts are ubiquitous 
in cells,  or would react with Hb++  02  yielding more  Hb+++(5  ). H 2o2  also 
would undergo reactions  (b  )  and  (c),  beside oxidation o£ Hb  o2,  as plausi-
ble  pathways under  the conditions likely to exist in the red blood cell. 
This picture is dramatically modified by  the presence in the red blood cell 
o£  enzymes  that greatly enhance  the rate o£  reactions  (a)  and  (b ), i.e. 
superoxide  dismutase  and hydrogen peroxide  disrnutase  (better known  as cata-
lase ). In the presence  o£  such disautases the concentration o£ o; and H 2o2 
drops,  so that reaction  (c)  is practically absent. Moreover  the dismutases 
prevent £ormation o£  1o2  in both reactions  (a)  and  (b)  (6).  The  combined 
action o£  the  two  dismutases  seems  therefore to be  an effective defense 
against oxidizing molecules arising £rom  Hb++  02,  as both  enzymes  appear  to 
be  localized in close contact with hemoglobin  (7).  A third defense  enzyme, 
glutathione peroxidase,  is on the  other hand  bound  to the red cell membrane 
and appears to be  specialized in the reduction o£  organic peroxides already 
formed  in the membrane  by  oxidants that escape all the defense  systems 
inside the cell (7).  However  it should have  a  role in the  scavenging  o£ -11-
H 2o2  itself in cases of acatalasia,  as  the  diffusion rate of H 2o2  is suf-
ficiently high to allow fast reacti  ·Jn  even with a  membrane  - bound  enzyme. 
It could be  concluded that most  of recent work  in the field has  been 
devoted to define  the chemical reactivity of the various reactive  oxygen 
derivatives,  the effect of specific catalysts on  their life time,  and  the 
role of hemoglobin and  drugs as a  source of oxidizing oxygen  species. 
However  a  definitive demonstration of a  role of these derivatives in pro-
ducing membrane  lipid peroxidation and hemolysis in physiological condi-
tions  is not  yet available.  Their  interactions with vitamin E  as a  membra-
ne  antioxidant,  though  supported  by  many  facts,  are still waiting for  a 
description at the molecular  level. 
On  the other hand  in vitro and in vivo evidence  seems  to support  an actual 
role of superoxide dismutase  and  glutathione peroxidase in balancing  the 
production of reactive oxygen derivatives from  oxy  Hb  (8-11). 
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RELATIONSHIP  BETWEEN  ENZYME  PROPERTIES  AND  THE  CLINICAL 
EXPRESSION  IN  GLUCOSE-6-PHOSPHATE  DEHYDROGENASE  (G6PD) 
DEFICIENCY 
W.  Schrl:Ster 
Kinderklinik of  the  Univeristy  of Gl:Sttingen 
Humboldtallee  38 
D-3400  Gl:Sttingen,  F.R.G. 
More  than 100 variants of  G6PD  have  been reported,  which are distin-
guishable  from  one  another  by  their kinetic characteristics,  electrophore-
tic mobilities and  substrate specificities. About  40  variants have  normal 
activity or mild enzyme  deficiency in red cells and  therefore are not asso-
ciated with any clinical manifestations. Another  group  of variants causes 
severe  enzyme  deficiency in red cells,  but requires exogenous  agents  such 
as drugs,  infections or fava  beans for  hemolysis  to occur.  Other variants 
are associated with chronic nonspherocytic hemolytic  anemia  even in the 
absence  of exogenous  agents. 
Many  investigations have  shown  that  the degree  of enzyme  deficiency 
measured  in hemolysates under  optimal conditions does not correlate well 
with  the clinical severity of the disease. Kinetic characteristics for  the 
substrate and coenzyme  of the variant enzymes  cannot fully explain the 
reasons for  the different hemolytic manifestations in the affected subjects. 
Therefore,  other properties of the abnormal  enzymes  and the  "physiologic" 
activity of  G6PD  within the intact abnormal red blood cells have  to beau-
cidated.  We  can demonstrate  the results in this respect on five newly cha-
racterized G6PD  variants which  we  found recently in Germany  and Switzerland. 
The  biochemical characterization of the variants was  performed on partially 
purified G6PD  preparations according  to  the recommendations  of the WHO 
scientific group.  For characterization the  enzymatic activity in hemolysa-
tes,  the Michaelis-Menten constants for  glucose-6-phosphate  and NADP,  the 
inhibition constant for NADPH,  the utilization of the substrate analogues 
for 2-desoxyglucose-6-phosphate,  galactose-6-phosphate and deamino  NADP, 
the  pH  activity curves,  the  thermal  stability and the electrophoretic mo-
bility were used. 
The  clinical severity of the five variants increased in the following 
order:  G6PD  Hamburg,  G6PD  Aarau,  G6PD  Hamm,  G6PD  Tarsus and G6PD  Bielefeld. 
No  correlation of the clinical picture and  the residual enzyme  activity was -13-
recognizable.  Between  the kinetic properties of the variant enzY.mes  and  the 
clinical severity some  parallels became  obvious.  The  variants with  severe 
hemolytic  anemia exhibited unfavourable kinetic parameters and  low  thermal 
stability. 
An  attempt was  made  to measure  G6PD  activity under  simulated physiolo-
gic conditions according  to YOSHIDA.  These  experiments demonstrated that 
variants with  severe hemolytic  anemia  (G6PD  Hamburg  and Aarau  )  exibit very 
low  activities under  ''physiologic" conditions whereas variants aS£"'r:iated 
with a  mild clinical course  (G6PD  Bielefeld,  Hamm  and  Tarsus  )  are more 
active within the cell. 
The  results clearly demonstrate  that enzyme  activity and kinetic cha-
racteristics determined in vitro under unphysiologic conditions  (at opti-
mal  pH,  in the presence of high concentrations of the  substrate and coenzy-
me,  in the absence of inhibitors)  often provide misleading information con-
cerning the real physiologic activity of the enzyme  in the variant cells. 
Kinetic analysis under  simulated physiologic conditions might  provide  some 
more  inshight into the molecular pathology of G6PD  variants. 
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GLUCOSE  6-PHOSPHA TE  DEHYDROGENASE  DURING  ERYTHROID  CELL  DIFFERENTIATION 
H.R.V.  Arnstein 
Biochemistry Department,  University of London  King's College, 
Strand,  London  WC2R  2LS,  U.K. 
Erythroid differentiation has  been investigated in a  number  of cells 
and  tissues,  including foetal  liver,  embryo  yolk  sac,  spleen,  Friend 
erythroleukaemic  spleen cells,  and  bone  marrow.  Using  bone  marrow  ery-
throid cells from  rabbits made  anaemic  by  injecting phenulhydrazine,  we 
have  investigated a  number  of biochemical changes associated with  the 
differentiation of these cells,  especially those related to the  synthesis 
of nucleic acids and proteins,  including  several  enzymes  (1-3).  For  this 
purpose,  the  development  of  a.  sui  table  technique for  separating cells at 
different stages of differentiation in sufficient quantitities for  bioche-
mical  studies was  essential. We  have used velocity sedimentation at unit 
gravity to separate  bone  marrow  erythroid cells into six distinct cell 
types,  namely proerythroblasts,  basophilic erythroblasts,  polychromatic 
erythroblasts and reticulocytes  (1  ).  This method  is especially satisfac-
tory for cells at  the later stages of development which  are separable with 
good  resolution. 
The  synthesis of both  DNA  and  RNA  was  found  to  be  essentially constant 
in terms of the polymerization of labelled precursor  (thymidine  or uridine) 
per cell up  to the polychromatic erythroblast stage,  when  nucleic acid 
synthesis rapidly ceased and was  no  longer detectable  in the  immediate 
progeny cells,  the early orthochromatic  erythroblasts.  On  the other hand, 
protein synthesis in terms of labelled leucine  incorporated per cell re-
mained active in all cells  (1)  although it decreased more  or  less in pa-
rallel with the reduction in cell volume,  which is characteristic of  the 
final  stages of erythroid cell development. 
Haemoglobin messenger  RNA  is already detectable in proerythroblasts 
and  basophilic erythroblasts  (4)  but haemoglobin synthesis only becomes 
quantitatively predominant  in orthochromatic cells after nuclear condensa-
tion  (2  ). Carbonic  anhydrase activity increases in parallel with haemo-
globin though  quantitatively to a  lesser extent.  The  activities of cata-
lase and adenylate  kinase also increase,  but  only after the final cell di-
vision (2). A number  of other enzymes,  including glucose  6-phosphate  de--15-
hydrogenase,  show  an approx.  ten-fold decrease  in specific activity at the 
time  of nuclear condensation (2).  The  observed loss in activity is partly 
accounted for  by  the  increased dilution of the  enzymes  owing  to the accumu-
lation of newly  synthesized haemoglobin,  but  some  degradation evidently 
also occurs at this time.  Thus,  in the case  of lactate dehydrogenase  we  ha-
ve recently shown  that there is a  selective degradation after nuclear con-
densation of lactate dehydrogenase  isoenzymes containing the M subunit  by  a 
proteinase present in lysosomes  (5  ). When  lysates of rabbit erythroid bone 
marrow cells were  analysed for glucose  6-phosphate  dehydrogenase activity 
after starch gel electrophoresis  (0.025  M sodium phosphate,  pH  7,  in the 
presence of NADP) a  minor  band with a  slower  a:.1odic  mobility was  found  to be 
present,  whereas this component  was  absent  in similar lysates from reticulo-
cytes. It is possible,  therefore,  that limited proteolytic degradation,  pos-
sibly by  a  lysosomal  enzyme  as in the case  of lactate dehydrogenase,  may 
contribute to  the  observeJ decrease  in glucose-6-phosphate dehydrogenase 
activity during  the final  stages of erythroid cell development. 
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SEPARATION  OF  ERYTHROCYTES  ACCORDING  TO  AGE  AS  A TOOL  FOR  INVESTIGATING 
G6PD  DEFICIENCY  AND  OTHER  ENZYMATIC  DEFECTS 
s.  Piomelli 
Department  of Pediatrics,  School  of Medicine 
New  York  University Medical  Center 
New  York,  U.S.A. 
Marks  and Johnson  (1) first demonstrated that certain enzyme  activities 
decline with aging of  the red cell. Their studies introduced the concept  of 
"age  dependent  enzymes"  and suggested that enzymatic activities may  decline 
during aging to a  level incompatible with cell survival.  Initial observa-
tions were  obtained utilizing the different osmotic  resistance  o£  cells o£ 
different ages.  Better separation o£  intact cells o£  different age may  be 
obtained by centrifugation,  after the initial observation that  reticuloc~ 
tend to concentrate in the upper part o£  the red cell column.  The  differ-
ence  in specific gravity with cell age  can be best exploited by  equilibrium 
centrifugation using density gradients.  Both continuous and discontinuous 
gradients  have  been utilized for this purpose.  Discontinuous  gradients  ap-
pear preferable and in our laboratory these methods  have  been used extensi-
vely £or separation of cells of progressively increasing age for metabolic 
studies  (2,  3).  Up  to few  years  ago,  most  o£  the  gradients had been prepar-
ed with crystalline bovine albumin;  more  recently a  different kind of mate-
rial,  Stractan II,  an arabino galactane polymer,  has  been utilized for  this 
purpose  (4).  This material  has  two  advantages;  the first one,  that it is 
extremely inexpensive,  and the  second,  that it is extremely easy to work 
with.  By  use  o£  this technique,  the rate of decline of glycolytic enzymes 
was  systematically studied. It is apparent  that all glycolytic  enzymes  pro-
gressively lose activity with aging of the cells,  however  in most  cases  the 
loss of activity is negligible and 120  day-old red cells still have  more 
than hal£  the activity o£  very young  red cells.  The  three glycolytic enzymes 
which exhibit  a  marked  rate o£  decline are  hexokinase,  pyruvate kinase  and 
aldolase.  Rate  o£  decline  o£  enzymatic activities measured by in vitro as-
says  do  not  reflect changes  in true intracellular metabolism.  In fact,  the 
assays  are performed in optimal conditions,  at substrate concentrations 
which permit maximal  enzyme  velocity. Within the cell,  individual  enzymes 
act only as  an integral part of the entire system due  to the interplay of 
substrates,  inhibitors and activators.  Therefore  a  better estimate o£  changes -17-
in metabolic capacity with cell aging is thus obtained by studies of actual 
utilization of  glucose  and production of lactate. A significant reduction 
in glucose utilization to a  value  of one-fourth of the initial rate is appa-
rent in 120 day-old cells. This  decreased metabolic  rate does not  imply me-
tabolic failure,  since the minimum  rate of glucose  does not necessarily 
imply metabolic failure and the minimum  consumption of glucose  is unknown. 
Of  greater importance  however is the fact  that stressed glycolysis  (in the 
presence of methylene blue and increased Pi)  decreases at a  faster rate  (5). 
As  a  consequence,  while young  red cells may  increase their glucose utiliza-
tion up  to tenfold in response  to stress,  old red cells with a  fixed low 
basal metabolic  rate have lost most  metabolic flexibility.  The  mechanism 
for this defect could be related to the peculiar rate of decline  of hexo-
kinase. 
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CORRELATION  BETWEEN  GSH  AND  ATP  LEVELS  AND  MEMBRANE  GLYCOPRO'miN 
MODIFICATIONS  IN  HUMAN  ERY'm:ROCY'IES 
C.  Balduini 
Institute o£  Biological Chemistry-Faculty o£  Sciences 
University o£  Pavia 
Pavia,  Italy 
The  glycoproteins of erythrocyte membrane  have  been widely investiga-
ted both with respect to their structure and  to their physico-chemical and 
functional properties  (£or  a  review  see Marchesi  and Furthmayr,  1976  ). In 
particular it was  pointed out that,  during physiological aging in the cir-
culation,  red blood cells undergo  a  loss o£  membrane  sialic acid  (Baxter 
and  Beeley 1975).  In the meanwhile  the role o£  surface sialic acid as a 
determinant  o£  erythrocyte life span was  proved  by  several groups  (Jancik 
and  Shauer  1974)  (Durocher et al. 1975)  (Gattegno et al. 1975)  (Balduini et 
al. 1977). 
In this laboratory it was  demonstrated  (Balduini et al. 1974)  that 
glycopeptides extracted by papain digestion £rom  old erythrocyte membranes, 
contain,  with respect  to those extracted £rom  young  membranes,  not  only a 
lower  amount  o£  sialic acid,  but also o£  galactosamine and  hydroxy-amino-
acids. Further investi£ations proved that both"ghost" membranes  and intact 
erythrocytes are able,  when  incubated at 37°  "in vitro",  to release in the 
medium  a  glycopeptide  (Brovelli et al. 1976)  (Brovelli et al. 1977). 
This glycopeptide  showed  the following  properties: 
-It contains sialic acid  (30-60%  o£  the total membrane  content),  gluco-
samine,  galactosamine,  galactose and mainly polar aminoacids. 
- It aggregates in aqueous  solutions. 
- It inhibits M- N haemagglutination. 
- Its release is pH  dependent with  two  optima at pH  7.4 and  4.6. 
- The  release £rom  "ghost" membranes  reaches its highest value after 
4-5  hours  of incubation at 37° C. 
- The  release £rom  intact erythrocytes reaches its highest value after 
24-30 hours  o£  incubation at  37°  C. 
These  properties and  the consideration that after incubation the  SDS-
polyacrylamide gel electrophoretic pattern o£  residual membrane  glyccpro-
teins is completely altered,  seem  to indicate that the  two  glycopeptides are 
a  fragment  o£  glycophorin. It can be  supposed that,  during incubation,  an -19-
autolytic mechanism  becomes  active on the membrane  removing  the  glycophorin 
fragment  exposed to the exterior of the cell.  The  same  mechanism could oc-
cur during erythrocyte aging and could be  responsible for  the modifications 
of membrane  glycoproteins,  contributing therefore to the removal  of the  old 
erythrocyte from  the circulation. Following the above  considerations  the 
study of the regulatory aspects of membrane  self-digestion process was 
undertaken and in particular the role of  some  metabolites correlated with 
energy and redox metabolism was  investigated. 
The  incubation of  "ghost" membranes  in the presence of A  TP  or  GSH  con-
centrations similar to the physiological ones,  results in a  complete  inhi-
bition of the sialopeptide release and  in a  quite normal  aspect of the 
electrophoretic pattern of membrane  glycoproteins.  The  other compouns  in-
vestigated  (GSSG,  NAD,  NADP,  NADH,  NADPH,  DTT)  did not  show  any effect 
(Brovelli et al. 1977). 
When  intact erythrocytes are incubated  "in vitro" in Krebs-Ringer 
phosphate  buffer, it can be  observed that the autolytic process starts 
after  9-12  hours when  a  30-50%  decrease of  GSH  and  a  90-95%  decrease of 
ATP  concentrations occur  in the cell. Moreover  if tne precursors of  GSH 
(8mM  cysteine,  13mM  glutamic acid,  24 mM  glycine),  adenine  (0.3  mM)  and 
glucose  (1.5  mM)  are  added to the incubation medium,  the  GSH  and ATP  con-
centrations keep  higher with respect to the control and  the  sialopeptide 
release after  30 hours is 30-50%  inhibited.  The  protective effect of  GSH  and 
ATP  precursors was  confirmed by the normality o£  the electrophoretic pattern 
of membrane  glycoproteins after incubation. 
To  verify if energy and redox metabolism can influence  the autolytic 
phenomenon,  experiments with erythrocytes from patients with  PK  or  G-6-PD 
deficiency were  recently undertaken. 
Self-digestion experiments carried out using PK  deficient red cells 
(5  cases), with a  low ATP  content,  indicated that  the sialopeptide relea-
se  starts earlier with respect  to the controls (after about  4  hours  of in-
cubation).  Similar results were  obtained by  the preliminary investigations 
with  G-6PD  deficient red cells;  the early sialopeptide release matches with 
a  more  rapid decrease of GSH. 
From  the  "in vitro" evidences  shown  above it can be  concluded that the 
structure of membrane  glycoproteins is strictly correlated with the redox 
and  energy metabolism of the erythrocyte.  Tne  intracellular GSH  and AT.P  con-
centrations seem  to control an autolytic mechanism which  removes  £rom  the 
membrane  a  glycopeptide which is a  fragment  of glycophorin. -W-
It can be  speculated that when,  during erythrocyte aging or in pathological 
conditions,  ATP  synthesis and  redox metabolism fall below  a  critical level, 
a  rearrangement of membrane  structure and  a  decrease  of surface negative 
charges occur.  These  membrane  modifications very likely are  a  signal for 
the recognition of the cells by  the haemocateretic organs and  contribute to 
their removal  from  the circulation. 
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GLUCOSE-6-PHOSPHATE  DEHYDROGENASE  VARIATION:  A  TOOL  FOR 
THE  STUDY  OF  X-CHROMOSOME  INACTIVATION 
S.  M.  Gartler 
Departments of Medicine  and Genetics 
University of Washington 
Seattle,  Washington  98195 
Genetic variants at  the X linked locus specifying the  enzyme,  glucose-
6-phosphate  dehydrogenase  (GGPD),  have  been very important  in the investiga-
tion of X-chromosome  inactivation  (XCI).  This developmental  event  (XCI)  in-
volves the random cytological and functional  differentiation of the  two  X 
chromosomes  in females  such that  one  X chromosome  becomes  permanently in-
active in each  somatic cell. In this way,  humans  and most  placental mammals 
achieve  dosage  compensation,  that is,  the equivalence of X linked gene  ex-
pression for females with  two  X chromosomes  and males with  one  X chromosome. 
Since  XCI  is random,  the  egg  transmitts an X chromosome  which is not 
predetermined regarding its activation state.  Therefore,  the  female  germ 
cells must  either never  be  subject  to XCI,  or  they go  through an activation 
reactivation cycle.  The  answer  to this last question depends  on when  XCI 
occurs;  that is,  before  or after germ cell differentiation. Viewed  from  this 
perspective,  the investigation of XCI  involves three  developmental phases: 
differentiated somatic cells,  germ cells,  and  the period between  zygote for-
mation and  the  onset  of XCI. 
The  first definitive demonstration of an X linked gene  exhibiting XCI 
involved human  G6PD  variants in fibroblast cell culture  (1).  Cloning  of 
cells from  heterozygotes  showed  expression of single alleles.  The  same 
approach was  used to demonstrate  that inactivation was  a  chromosomal  event, 
by  cloning a  fibroblast culture from an individual heterozygous at both  the 
G6PD  and  PGK  loci  (2).  The  first demonstration of significant variation in 
normal  human  tissues was  in hair follicles from  individuals heterozygous 
for  the Mediterranean G6PD  deficiency variant  (3).  Since that  time  the use 
of hair follicles has  become  an important clinical tool for diagnosing the 
heterozygous condition in X-linked disease  (4).  G6PD  variants have also 
been extremely useful in studying  tumor  origin and development  (5,6).  The 
existence of mosaicism implies  the possibility of selection and apparent se-
lection in somatic cells has  been shown  in Mediterranean G6PD  heterozygotes -n-
(7,8). 
Though  XCI  inactivation appears  to be  a  stable event  in differentiated 
somatic cells,  the situation in germ cells must  be  different.  Studies with 
G6PD,  both in the mouse  and humans,  have  shown  that  both X chromosomes  are 
active in the  oocytes  (9,10).  In humans  this demonstration has  involved the 
hybrid band pattern seen in G6PD  heterozygous cells when  both X chromosomes 
are active.  The  critical question now  is whether  both X chro.osomes are 
active  throughout  germ  cell ontogeny or whether  the X chromosomes  go  through 
an activation:  reactivation cycle.  Some  evidence,  both cytological  (11)  and 
biochemical  (12),  suggests that the entire embryo  is subject to XCI  and 
that  the  germ  cells undergo  a  reactivation at  some  point during their onto-
geny.  However,  the data on this important point are controversial  (13  ),  and 
it is hoped that future work  with  G6PD  variant may  clear up  this matter. 
It is clear that the  two  X chromosomes  in the female  zygote are equiva-
lent with respect  to their activation states.  The  evidence is definitive 
that XCI  has not  occurred by  the first four  divisions and may  not  occur un-
til implantation.  However,  it is not clear as to whether  both X chromosomes 
at the early stages of development  are active.  Most  gene  products that have 
been examined at these early stages of development  do  not  appear  to increase 
in proportion with  the  growing  embryo.  The  most  likely explanation of this 
phenomena  is that embryonic  transcription of these  genes is not  occurring 
and  that  the  observed  gene  products  are maternal in origin.  G6PD  activity 
is an example  of this type;  the levels of G6PD  activity remain fairly con-
stant per  embryo  throughout preimplantation development  in the mouse,  and 
distributions of single embryo  values  show  a  unimodal distribution. However, 
two  other X linked traits(« galactosidase and hypoxanthine  guanine  phospho-
ribosyl  transferase)  exhibit significant increases in activity levels per 
embryo  during  preimp~antation development  (14,  15).  Studies of individual 
embryos  for  these  two  traits reveal  bimodal  distributions about  the  third 
day of development.  It remains to be  seen whether  the  two  classes represent 
female  and male  embryos,  and if so what  bearing  these findings will have  on 
the  question of dosage  compensation during preimplantation development. -~-
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BIOCHEMICAL  ASPECTS  OF  GLUCOSE  6-PHOSPHATE  DEHYDROGENASE  DEFICIENCY 
De  Flora A.,  Morelli A.,  Benatti u.,  Fra~cio M.,  Gaetani F.G. 
Departments  o£  Biochemistry and  o£  Hematology, 
University o£  Genoa 
Genoa,  Italy 
Synthesis o£  a  suitable affinity adsorbent,  agarose-linked adenosine 
2',5'-P2  (1),  permits the concurrent puri£ication.o£ a  hitherto unrecogni-
zed  NADP  (H)-binding protein,  designated FX  (2,  3)  and  o£  Glucose  6-phospha-
te dehydrogenase  (G6PD)  £rom  human  erythrocytes. 
FX  is composed  o£  two  apparently identical polypeptide chains ot NADPH 
(3,4).  The  dissociation constants towards  both dinucleotide forms  were de-
termined spectro£luorometrically and  found  to  be,  ~DP  =  1.8 x10-7 M and 
~ADPH =  1.0x10-B M.  The  Biological £unction o£  this holoprotein,  which is 
also present in leukocytes and platelets and absent in plasma,  is still 
unknown.  FX  was  not  identified with any  o£  a  number  (approximately 30  )  o£ 
erythrocyte enzymes  nor could it be  qualified as a  discrete form arising 
£rom  breakdown  o£  G6PD  (5). 
A solid phase radioimmunoassay was  developed which  enables quantita-
tion o£  immunologically cross-reacting material  (CRM)  to FX  in crude as 
well as in purified systems  (5).  A preliminary screening had  shown  signifi-
cantly higher levels o£  FX  CRM  in erythrocytes £rom  subjects affected by 
G6PD  deficiency and having the Mediterranean variant  o£  this enzyme  protein 
compared with normal  subjects  (5). A further analysis,  besides confirming 
such  quantitative difference on an  average,  revealed a  normal  distribution 
curve  o£  FX  in subjects with  G6PD  B,  while in hemizygous males having G6PD 
Mediterranean there was  a  considerable heterogeneity o£  FX  CRM  levels  (6): 
thus,  these were  scattered £rom  normal values  (in approximately 20%  o£  the 
G6PD  deficient subjects tested)  through consistently increased figures  (up 
to fourfold the mean  o£  normal  individuals). 
A second aspect  o£  G6PD  deficiency which was  investi£ated in our  labo-
ratory deals with the molecular mechanisms  underlying the defect o£  cataly-
tic activity.  These  were  examined  in two  different genetic variants o£  the 
enzyme,  I.E.  G6PD  Mediterranean and  G6PD  Seattle-like.  Three  methodologi-
cal approaches were  followed:  1)  a  highly specific solid phase radioimmuno-
assay o£  G6PD,  2)  a  single step,  rnicroscale purification procedure,  based 
on  the  above  mentioned affinity adsorbent,  whereby  G6PD  and  FX  can be  con-
currently isolated £rom  single individuals  (3  ml  volumes  o£  erythrocytes), -~-
and  3)  fractionation of erythrocytes of different age  by centrifugation on 
discontinuous density gradients  (7 ). These  techniques enable to measure  the 
specific activity (catalytic activity/mg of G6PD  protein)  of the enzyme  va-
riant under  study in lysates from whole  erythrocyte populations,  in lysates 
from erythrocytes of different age  and  in purified samples.  The  results in-
dicated that the Seattle-like variant has nearly normal catalytic function 
and  the related defect is accounted for  by  a  reduced amount  of enzyme  pro-
tein because  of an enhanced in vivo  breakdown.  Oonversely,  both an impaired 
catalytic efficiency and  a  consistently lowered amount  of enzyme  protein 
(due  to a  dramatically accelerated decay during erythrocyte aging)  are 
responsible for  the  severe defect of activity associated with  the Mediter-
ranean variant of G6PD  (8  ). 
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GENETIC  POLYMORPHISM  AND  KINETICS  OF  NORMAL  AND  VARIANT  G6PD 
L.  Luzzato,  C.  Mareni,  U.  Testa,  M.  DrUrso,  G.  Battistuzzi 
Institute Internazionale di  Genetica e  Biofisica,  Napoli,  Italy 
G.J.F.  Esan 
Department o£ Hematology,  University ot Ibadan,  Nigeria 
G.  Modiano 
Istituto di  Genetica,  Universita di  Roma,  Italy 
We  have  presented data on  two  aspects of the  genetic polymorphism of 
G6PD.  Firstly,  we  have  summarized  the  information that comparative  studies 
on several variants can yield with respect  to the  functional properties of 
this enzyme  in vitro and in vivo.  We  have  confirmed previously published 
evidence that the saturation curve of G6PD  is hyperbolic with respect  to 
one  substrate,  G6P;  but  sigmoid with respect to the  other  substrate,  NADP. 
The  cooperative  binding  of NADP  is a  feature exhibiting specific changes 
in the products of different mutations.  Thus,  for  instance,  the maximum 
slope of Hill's plots, i.e.  the  empirical~ value,  varies in 8  different 
variants from  1.1  to 1.8. Furthermore,  w~ have  shown  that cooperativity is 
a  sensitive function of pH,  of Mg2+  co~centration, and especially of  ionic 
strength.  The  mechanism  of the  increase in binding affinity with increa-
sing NADP  concentration is not yet clear,  but it is likely to have consi-
derable  importance in the regulation of  G6PD  activity in response  to chan-
ges in the intracellular environment  in the erythrocyte.  We  have also 
shown  evidence that a  point mutation affecting the primary structure of 
the enzyme  - a  single amino  acid replacement  - can affect its quaternary 
structure:  specifically,  the dime/tetrarner equilibrium. 
Secondly,  we  have  tested the possibility that electrophoretically 
undetectable  G6PD  variants may  exist in the normal  population.  In order  to 
do  this,  quantitative determination of  G6PD  activity was  carried out  in 
219 male  Nigerian children of 86  mothers with known  Gd  genotype.  The  rela-
tive intrasibship difference in G6PD  activity (normalized to the lowest 
value within the  sibship)  was  below  0.18 in all cases but  one when  the 
children were  known  to have  the  same  Gd  allele  (identical by  descent  ); 
whereas it was  higher than 0.18 in 18 out  of  33  sibships where  children 
might  have had either of the two  maternal  Gd  alleles.  G6PD  from  10  (8  G6PD 
B and 2  G6PD  A)  children belonging to 4  of  the  sibships with high quanti-
tative variation in G6PD  activity was  partially purified and  extensively -27-
characterized.  The  8  G6PD  type  B samples fell unambiguously into two  clas-
ses on the  basis of Km  values for  glucose  6-phosphate  (determined at va-
rious pH  values),  and KCl  gradient elution from DEAE-Sephadex  columns. 
The  two  G6PD  type A samples were  also different from  each  other  by  the  sa-
me  criteria. We  conclude  that  "normal"  G6PD  .is genetically heterogeneous 
and  that  the structural  Gd  alleles concerned are all polymorphic  in the 
Nigerian population.We  believe this is the first instance where  a  human 
enzyme  polymorphism,  not associated with  enzyme  deficiency,  is revealed 
by  an approach  other  than electrophoresis. -28-
NEXT  ASPECTS  OF  INTRACELLULAR  REGULATION  OF  NORMAL  AND  GLUCOSE-6-PHOSPHATE 
DEHYDROGENASE  DEFICIENT  ERYTHROCYTES 
G.F.D.  Gaetani 
Cattedra di Ematologia,  Istituto Scienti£ico di  Medicina  Interna,Universi~ 
di Genova,  Italy 
Several mechanisms  recently proposed £or the regulation o£  the hexose 
monophosphate  shuntrequire  the concentration o£  NADP  to be  low  or that  o£ 
NADPH  to be high.  Recent  studies  (1)  indicate that  glucose-6-phosphate  dehy-
drogenase,  the first enzyme  o£  the hexose  monophosphate  shunt,  o£  human  red 
cells is under severe intracellular restraint even when  these conditions 
do  not exist.  In human  erythrocytes with low activity variants o£  glucose-
6-phosphate  dehydrogenase,  measurements  o£  the rate o£  oxidation of  1-14c 
glucose  show  that the enzyme  is operating at  a  rate much  closerto its maxi-
mum  than in normal cells. This  requires that the ratio o£  inhibitory NADPH 
to NADP+  be  much  lower in the variant cells than in the normal cells. A 
low  NADPH/NADP+  ratio in unstressed cells,  deficient in glucose-6-phosphate 
dehydrogenase,  have  been demonstrated (2),  and a  small  increase in oxidative 
rate,  induced in vitro by naphtol  (3)  and in vivo by £ava beans  (4),  caus-
ed a  further decrease in NADPH  level.  The  reason £or the limitation on  max-
imum  intracellular activity is unknown.  Recent  studies o£  the hexose  mono-
phosphate shuntactivity and  o£  NADPH  level o£  normal  and  glucose-6-phosph~ 
d  d  £ ·  ·  h  h  ·  ·  14c  o  1  ehydrogenase  e  1c1ent eryt rocytes  s  ow  a  prompt  1ncrease 1n  2  evo u-
tion and  a  rise in NADPH  levels (5).  Since  the concentration o£  hemolysates 
is comparable  to that of intact erythrocytes,  the relief o£  the restraint 
on  glucose-6-phosphate dehydrogenase  through dilution-dependent  dissocia-
tion £rom  inactivator or inhibitor is excluded.  The  possibility that the 
intracellular restraint may  result £rom  compartmentalization o£  glucose-6-
phosphate  dehydrogenase  and substrates or £rom properties o£  the intact 
membrane  o£  the erythrocytes could be  suggested. 
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ELECTROPHORETIC  AND  IMMUNOCHEMICAL  PROPERTIES  OF  MOUSE 
GLUCOSE-6-PHOSPHATE  DEHYDROGENASE 
G.  Yagil 
Department of  Cell  Biology 
The  Weizmann  Institute of Science 
Rehovot,  Israel 
An  important difference  in the  behavior  of glucose-6-phosphate  dehydro-
genase  (G6PD)  in liver with respect  to most  other tissues,  including  ery-
throcytes,  is that its activity can be  varied by  a  considerable factor  (up 
to15-fold)  in response  to a  variety of dietary and other  signals.  In ery-
throcytes,  one  can readily expect  the mechanism  of formation of new  enzyme 
molecules  to  be  wholly or partly absent.  This is not  the case  in tissues 
like muscle which  are also noninducible,or  in uterus,  where  enzyme  activity 
may  increase,  but  in response  to estradiol treatment rather  than to dietary 
changes.  It seems,  therefore,  that  the mechanisms  by  which  a  cell responds 
to  the various activating signals are present  to different extents in diffe-
rent tissues.  Still,  a  more  trivial explanation may  exist,  such as  the exis-
tence  of totally different kinds  ("isozymes")  of  G6PDH  in induced tissues. 
To  find  out whether  this is the case,  we  examined  the properties of 
G6PD  in liver and other tissues,  by  a  variety ofaectrophoretic and  immune-
chemical  techniques.  The  technique which  proved most  useful was  electropho-
resis of the native enzyme  on acrylamide  gels.  The  detailed investigation 
of the  patterns obtained  (Hizi  and  Yagil,  Europ.  J.  Biochem.  45,  201,  1974  ) 
indicated several features which may  be  of considerable  importance  to  the 
study of enzyme  variants.  The  typical pattern obtained when  a  cytosolic pre-
paration is electrophoresed by  the classical Orenstein-Davis procedure and 
stained for  G6PD  activity can be  seen in Figure 1.  This pattern consists of 
three closely spaced bands,  the  intensity of which  is much  higher in liver 
homogenates  from  induced mice  th~ from  repressed  o~es. No  such  difference 
in intensity can be  seen in the erythrocytes from  the  same  mice. 
At  first,  we  assumed  that  the  3  bands may  represent different isoen-
zymes  in the livers. A more  detailed study revealed,  however,  that these 
bands are  interconvertible.  Thus,  when  a  fresh and well centrifuged prepa-
ration,  protected by  NADP,  is examined,  only the  slowest  band  of the triplet 
is observed.  Upon  standing this is converted first into  the  medium  band  and -31-
finally into the fast migrating band.  When  such  "aged" preparations are in-
cubated with 2  mM  mercaptoethanol  and  1  rnM  NADP,  the  slow  band is reformed. 
This means  that  the relative intensities of the  three  bands are determined 
after disruption of the cells. In other words,  only one  form  of glucose-6-
phosphate dehydrogenase  is present in the cytoplasm of liver,  erythrocytes 
and  other tissues examined  by us,  and  the  three  bands represent postdisrup-
tional modifications of the  enzyme. 
The  triplet can be  seen not  only in mouse  erythrocytes but also  in hu-
man  erythrocytes  (band No.  3,  Fig.  1).  The  triplet pattern can also be  di-
scerned on electrophoresis on starch gel and cellulose acetate,  but  the  su-
perior resolution of acrylamide is required to bring it out in detail.  This 
may  have  important consequences on  the analysis of variants;  apparently 
narrower or  slightly displaced  bands  may  well represent differences in the 
cellular modifying  system rather  than of the  enzyme  molecule per se. It is 
recommended  to examine  variant preparations,  both fresh and aged as well as 
under reactivating conditions,  before a  conclusion regarding a  difference 
is arrived at. An  example  of deficient enzyme  is shown  in Fig.  2,  where 
G6PD  purified from  a  Tel  Hashomer  variant of the enzyme  is compared with 
the  normal  enzyme.  The  triplet can be  clearly observed in both preparations. 
In the variant enzyme  an a?preciable amount  of the  slower  dimer  band,  as 
reported  by  Kirkman,  Ramot  and  Lee  (Bioch.  Gen.  3:137,  1969)  can also  be 
seen. 
A further  approach  to the characterization of  enzyme  in different tis-
sues or metabolic  states is by  the use  of specific antiserum raised against 
mouse  liver G6PD  purified by  the affinity chromatographic  procedure of  L~Aed 
et al.  (Biochim.  Biophys.  Acta  304:201,  1972).  One  particularly useful  immu-
nochemical  technique  is rocket  immunoelectrophoresis,  first applied to G6PD 
by  Kahn,  Dreyfus and co-workers  (this symposium).  The  area of the  "rocket" 
formed  is proportional to  the  amount  of antigen present,  so  that  the rela-
tive amount  of antigen in induced~· prepressed preparations can be  esti-
mated  independent  of the  enzyme  activity.  Such  a  comparison has made  it pos-
sible to conclude  that  the  enzyme  has a  constant  specific activity whether 
induced or repressed,  and has confirmed the  suggestion that only a  single 
form  of  the enzyme  exists in the  mammalian  tissues examined.  The  same  techni-
que  was  also used to show  that  the  three  bands  obtained upon electrophore-
sis are antigenically equivalent. 
The  immunochemical  approach can also  be  used in order to determine  the 
rates of G6PD  synthesis  (Eisenbach and  Yagil,  in preparation).  Two-dimensio--32-
nal analysis of the  irnmunoprecipitate  proved to be  essential in obtaining 
reliable values for  the  incorporation of labeled aminoacids in  G6PD  mole-
cules.  In this procedure,  the enzyme  is electrophoresed in one  dimension in 
the native form,  and  then the  subunits are further  separated by  electropho-
resis in SDS  in vertical direction.  In this way  it can  be  shown  that  the 
increased levels of the  e~zyme in mice  induced  by  a  fatless diet are con-
nected with a  parallel increase  in the rate of synthesis of the  enzyme. 
I  hope  that  some  of the  methodologies referred to in this report will 
prove useful in the  analysis of variant G6PD  in cases of deficiency in 
erythrocytes. -34-
SOURCES  OF  OXIDATION  AND  REDUCTION  EQUIVALENTS  IN  THE  RED  CELL 
S.M.  Rapoport 
Institut fUr  Physiologische  und  Biologische Chemie 
Bereich Medizin  der  Humbdt-Universit~t, 
Berlin,  DDR 
There  are  two  types of stresses,  which  may  lead to  the destruction 
of the  red cell: 
1  )  Interference with maintenance of ATP 
The  resistance of the cell to changes of ATP  is provided by its fine-
ly regulated mechanisms  of ATP  maintenance,  which are part of the self re-
gulation of  the  glycolytic  system.  I~basic features are: 
a)  the existence of a  time hierarchy of enzymes.  The  enzymes  differ by  four 
orders of magnitude  in their relaxation times.  This means  that  some  reac-
tions  are. always near equilibrium while  others are  so  slow  that their chan-
ges  may  be  neglected.  Only  some  reactions need  be  considered for  the usual 
metabolic changes. 
b)  For  the control of the  glycolytic flux  only three nonequilibrium enzy-
mes  are  important;  they are  the hexokinase-phosphofructokinase  (PFK)  system 
and  the  system of ATP-ases. 
c)  The  ATP  consumption is the  major factor  determining the magnitude  of the 
glycolytic flux. 
d)  There  exist two  different mechanisms  for  the control of the flux,  an 
allosteric one  by  means  of the  HK-PFK  system and  a  stochiometric  one  pro-
vided  by  the DPG  shunt. 
The  problems of ATP  production are well .understood while  those  of ATP 
consumption are not.  The  known  transport ATPases  account for  no  more  thaa 
1/4 of the ATP  consumption. 
Glycolysis and  the pentose phosphate pathway are connected by  G-6-P.  Here 
there is a  competition between the  PFK  and  the G6PD.  The  share of the  PFK 
is determined  by  positive effectors such as AMP  and P.  and  by  the negative 
1. 
effector H+  ions.  The  activity of the  G6PD  is mostly affected by  the con-
centration of NADP.  It is conceivable that  the- effect of pH  has clinical 
implications which  may  be  even more  severe with  G6PD  mutants with  lowered 
affinities for  their substrates. 
Of  theoretical interest is the fact  that glycolytic intermediates may  serve -~-
bance difference  spectrum and fluorescence emission spectrum. 
Drastic denaturation of the enzyme  by urea and  acid treatment did not 
suppress  the difference of isoelectric point  between native and hyperanodic 
forms  of glucose-6-phosphate dehydrogenase. 
From  our data we  may  suggest  that the conversion into hyperanodic 
forms could  be  due  to the covalent binding on the enzyme  of a  degradation 
product of the pyridine nucleotide coenzyme.  This modification could consti-
tute a  physiological transient step  toward  the definitive degradation o£ 
the  enzyme. -36-
ELECTRON  MICROSCOPY  OF  PROTEIN  MOLECULAR  STRUCTURE  WITH 
SPECIAL  REFERENCE  TO  GLUCOSE  6-PHOSPHA 'IE  DEHYDROGENASE  ( G6PD) • 
N.G.  Wrigley 
Mill Hill,  London,  -u.r. 
Electron microscopy can be  used  to study G6PD  morphology at three 
structural levels: 
a)  the cellular level,  where  erythrocyte shape,  and particularly where 
the condition and  topography of its membrane  are important.  Macroscopic  phe-
nomena  such as  the distribution of  G6PD  within the cell and its possible 
attachment  to the membrane,  may  be  investigated by complexing the  G6PD  with 
specific ferritin-tagged antibody and  preparing serial sections. 
b)  at  the  level of quaternary structure  (e.g. Wrigley et al., J. Mol. 
Biol.  68,  483-499,  1972)  where  monomer-dimertetramer  transitions are concer-
ned using  equilibrium and  time-dependent conditions. 
c) at finer levels in a  detailed definition of tertiary structure and 
possible changes  of that structure.  Even finer details such as location of 
the  NASP-binding  site, could be  studied using an NADP-specific  antibody as 
marker  (e.g.  as Wrigley et al., J. Mol.  Biol.  109,  405,  1977  ). 
Studies in category b)  are limited by  conventional  techniques of nega-
tive staining to a  resolution of 30 A  at best. However  current development 
in reducing molecular damage  by  staining and electron irradiation can be 
0 
expected to  improve  this to a  reliable 20-18 A.  Computer  modelling in which 
the negative stain distribution is simulated  (Wrigley et al., J. Microscopy, 
in preparation)  should  improve  this to perhaps  15 K  in one  or  two  years  by 
permitting the  integration o£  information from many  individual molecules 
and  so  enhancing pictorial signal noise. 
Studies in category c) will depend critically on the availability of 
crystals of the  three molecular forms  of  G6PD.  This could permit total eli-
mination of negative stain and vastly reduced electron dosage.  Combined 
with Fourier filtering and reconstruction procedures,  this might yield in-
formation at the 10 K level or better.  Given  the availability of large 
( >  1  mm)  crystals however,  these problems are best transferred to X-ray 
0  •  crystallography with a  potential of 2  A  resolut~on. 
If the  above could yield morphological features fine enough  to distin-
guish  G6PD  variants  (though  their differences are probably below  5 K),  then -n-
electron microscopy could be  of further value in any proposed mass-screening 
project forming part of a  public health programme.  In princi~, 50x10-9gm 
of highly purified G6PD  would  be  sufficient for morphological comparison 
with previously determined and computer-stored structural information.  This 
could also offer great rapidity with  the  typing  of several hundred  samples 
per man-day.  Limiting factors would  be  1) equivalently rapid enzyme  purifi-
cation procedures and  2)  sufficient investment in electron microscope, 
picture scanning and computer equipment. -38-
BEHAVIOR  OF  GLYCOLYTIC  METABOLI'l.ES,  PYRIDINE  COENZYMES,  ADENINE 
NUCLEOTIDES,  AND  GLUTATHIONE  DURING  FAVA-BEAN  CRISIS 
P. Arese,  G.F.  Gaetani,  C.  Mareni,  T.  Meloni 
Istituto di Chirnica  Biologica and Istituto di Clinica Pediatrica, 
Universita di  Sassari 
Cattedra di  Ematologia,  I.S.M.I.,  Universita di  Genova  (Italy) 
The  levels of some  glycolytic metabolites,  2,3-DPG,  ATP,  pyridine 
coenzymes,  total glutathione,  and  the  total glycolytic flux were  assayed 
in G6PD-deficient erythrocytes 
1. in steady-state conditions 
2.  during fava-bean hemolytic crisis 
2.1. within 24 h  from  ingestion (early crisis) 
2.2.  between  36  and  72  h  from  ingestion (late crisis) 
3.  during mild  crisis occurring almost without hemolysis. 
4.  The  same  parameters were measured also in incubation experiments at dif-
ferent  pH-values in order to evaluate  the  influence  of G6PD-deficiency on 
the glycolytic regulation. 
1.  Steady-state conditions 
Significant differences were  noted in the levels  (nmoles/ml  RC  )  of 
2,3-DPG  (normal  (N)  5150;  deficient  (D)  3600),  NAD  (N  21;D  38),  NADH/NAD 
(N  2.57;  D 1.16),  NADP  (N  1;D 17),  NADPHjNADP  (N  30;D  2.53),  and  total  GSH 
(N  2364;D  1433). 
2.1.  Early crisis 
Significant differences were  noted in the levels of NADPH  (deficient 
controls  (DC)  43- early crisis (EC)  26),  NADPHjNADP  (DC  2.53;  EC  0.61),NADP 
(DC  17;  EC  42),  total  GSH  (DC  1433;  EC  780),  and  total glycolytic flux 
(DC  1316;  EC  1843  ). 
2.2.  Later crisis 
36  to 72  h  after ingestion,  significant differences were  remarked  in 
the levels of 2,3-DPG  (DC  3600;  late crisis (LC)5900),  ATP  (DC  1208;  LC  16971 
total glycolytic flux  (DC  1316;  LC  2100),  and  NADPHjNADP  (DC  2.5;  LC  0.63). 
3.  Mild crisis 
During mild crisis there was  no  drop  in total  GSH  but a  sharp  decrease 
in the ratios NADH/NAD  (DC  1.16 ;mild crisis  (MC)  0.8),  and  NADPjNADP 
(DC  2.53;MC  0.4). -39-
4.  Incubation experiments 
Lower  NADH/NAD-ratios  measured in G6PD-deficient red cells (see  sect.1) 
are  expected to influence and activate the glyceraldehyde  3-phosphate dehy-
drogenase-step.  In fact,  deficient red cells accumulate less dihydroxyaceto-
ne  phosphate,  glyceraldehyde-3-phosphate and .fructose 1,6-bisphosphate at 
alkaline pH,  and  produce more  lactate at all pH-values  studied sofar  (pH 
6.80,  7.00,  7.40,  7.80,  8.00  ).  Lower  2,3-DPG  and  higher intracellular 
inorganic P  levels were  measured at all pH-values. 
CONCLUSIONS 
T.he  most  sensitive parameters modiBed  by  fava-bean ingestion were  the 
redox couples NADH/NAD  and  NADPH/NADP:  total  GSH  dropped  only when  hemolysis 
occurred.  Except  for  a  transient and compensatory increase in post-hemolytic 
anemia,  2,3-DPG  is constantly lower  in the deficient subjects.  The  redox 
shifts correlated with the G6PD-inactivity influence glycolysis and increase 
the lactate output. -40-
PREPARATION  AND  PROPERTIES  OF  RESEALED  RED  CELL  GHOSTS 
H.  Passow 
Max  Planck Institut £Ur  Biophysik 
Frankfurt  am  Main,  Germany 
The  preparation of resealed ghosts  (6,7)  aims at replacing the cell 
contents by  solutions of one's  own  choice.  Cell contents can be  removed  by 
various forms  of hemolysis,  including osmotic hemolysis,  to which  the  pre-
sent paper is confined. After hemolysis,  the  ghosts can be  equilibrated with 
solutions o£  the desir·ed composition.  Incubation at 37°  C for  15-45 minutes 
finally leads to a  recovery of the  imperviousness of the cell membrane 
("resealing"  (2)).  The  present paper deals with: 
{1)  the maximalization of  the yield o£  resealable  ghosts in a  popula-
tion, 
(2)  the maximalization of impermeability of those  ghosts in a  popula-
tion that can  be  resealed, 
(3)  the minimalization o£  the residual cell contents in resealable 
ghosts,  and 
(4)  the preparation of vesicles which  are  surrounded  by  the original red 
cell lipid bilayer containing  one  or a  few  of the  original membrane  proteins. 
(1)  The  yield o£  resealable  ghosts is maximal  i£ hemolysis is pertormed 
at 0°  C,  pH  6.  Under  these conditions the presence  or absence  of alkaline 
earth metal  ions  or complexing agents is o£ little consequence  £or  the yield. 
I£ hemolysis is performed at more  elevated temperatures,  the presence  of 
complexing agents at  the instant of hemolysis decreases the number  of resea-
lable ghosts while  the presence  o£  Mg  or  low  concentrations o£  Ca  increases 
the yield  (1,  3,  5). 
(2)  Resealing is a  relative term.  Those  ghosts in the population that 
can be  resealed may  be  more  or less permeable  to a  given solute.  The  permea-
bility for K is minimized  by  a  wash  o£  the resealed ghosts in a  medium  con-
taining a  complexing agent.  Hemolysis in the presence of Mg  or Ca  (which 
produce a  temperature-dependent effect  on  the yield of resealable ghosts) 
decreases  the K permeability of those  ghosts that did successfully reseal 
(8). 
(3)  A combination of  the principles described under  (1)  with column 
chromatographic  techniques allows the preparation o£  ghosts that are virtual--41-
ly free  of hemoglobin and still can be  resealed by  subsequent  incubation at 
37° c  (9). 
(4a)  Spectrin and  the majority of the red cell membrane  proteins can 
be  removed  by  exposing red cell ghosts  to incorporated trypsin.  The  intrin-
sic membrane  proteins are partially degraded,  but fragments  of the protein 
in band  3  or  two  other proteins still remain associated with  the membrane 
("enzymatic cleaning",  (4)).  The  treated ghosts tend to form  vesicles which 
are leaky for K but not for  anions and which  can be  used for  the  study of 
the function of the protein in band  3  in anion transport. 
(4b)  Extraction with slightly alkaline solutions of  T.rition X-100 re-
moves  virtually all membrane  proteins except  the protein in band  3.  Vesicles 
can be  formed  that can be  used for  the  study of anion transport  ("chemical 
cleaning",  (10)). 
REFERENCES 
1)  Bodemann,  H.  and  Passow,  H.  (1972).  J. Membrane  Biol.  8:  1 
2)  Hoffman,  J.F.,  Tosteson,  D.C.  and  Whittam,  R.  (1960).  Nature  185:186. 
3)  Lepke,  s.  and  Passow,  H.  (1972).  Bi~him. Biophys.  Acta 255:696 
4)  Lepke,  s. and  Passow,  H.  (1976).  Biochim.  Biophys. Acta 455:353. 
5)  Schwoch,  G.  and Passow,  H.  (1973).  Mol.  Cell.  Biochem.  2:197. 
6)  Straub,  F.B.  (1953  )  Acta Physiol.  Hung.  4: 235. 
7)  Teorell,  T.(1952) J.  Gen.  Physiol.  35:669. 
8)  Wood,  P.  (1977).  Proceedings of the  International Union  of Physiological 
Sciences,  Volume  XIII, Abstracts of Volunteer Papers.  July 18-23, 
1977,  Paris,  p.  819. 
9)  Wood,  P.  (1977). Abstracts of the 11th FEBS  Meeting,  Copenhagen,  August 
1977,  Abstract number  A4-13  655. 
10)  Wolosin,  J.M.,  Ginsburg,  H.  and  Cabantchik,  z.  I.  (1977)  J.  Biol.  Chern. 
252:2419. -42-
FACTS,  AR'IEFACTS  AND  FUTURE  TRENDS  IN  I SCELECTRIC  FOCUSING 
P.G.  Righetti 
Department  of Biochemistry,  University of Milano,  Via Celoria 2 
Milano  20133,  Italy 
With  a  resolving power  of at least 0.02  pH  units  (in pi  differences  ) 
(1  )  isoelectric focusing  (IEF)  represents one  of the most  powerful  tools 
today available  to  biochemists and  genetists.  In one  of its most  promising 
adaptations,  IEF  is performed in gel  slabs,  run horizontally,  and  the  sample 
is applied to  the  gel matrix  soaked in a  piece of filter paper  (2).  Up  to 
40  samples can thus  be  handled  simultaneously.  IEF  has already found  seve-
ral clinical applications. It has  been successfully used in bidimensional 
mapping  of  serum proteins  (3,4 ). In studying the polymorphism  of~  1-anti-
trypsin  (P.  system or protease  inhibitor)  17  alleles have  been characte-
1 
rized so far  in human  patients.  Of  these,  the  MM  phenotype is the most  com-
mon  one,  while  the  ZZ  phenotype represents one  of the most  severe cases, 
since  the carrier exhibits a  severe a 1-antitrypsin deficiency associated 
with lung  and hepatic disease.  These  studies have  been made  possible  by  the 
use  of very shallow pH  gradients  (spanning  ~ of a  pH  unit)  and high volta-
ges,  thus  increasing the resolution while maintaining  sharp protein zones 
( 5, 6) • 
We  have  applied  IEF  to the  study of chemically modified as well  as ge-
netic variants of hemoglobin  (Hb  )  (7-10).  Our  results are  summarized  in 
Table I. 
TABLE  I 
pi's of genetically and chemically modified hemoglobins 
Protein (pi)  pi  No.  Residues  No.  charges 
HbA  (7.0)  HbS  (  2  2 
6Glu--Val)(7•25)  0.2  2  2 
HbA  (7.0)  HbC  (  2  2 
6Glu-Lys)(7•4)  0.4  2  4 
26 
HbA  (7.0)  HbE  (  2  2 
Glu-Lys)(7•4)  0.4  2  4 
HbA  (7.0)  HbMalmB(  2  2  97His-Gln)(6.9)  0.1  2  1 
HbA  (7.0)  HbWood(  2  2  97His-Leu) ( 6. 9)  0.1  2  1 
HbA  (7.0)  HbAc(  ~  ~)  (6.9)  0.1  4  1 




It can be  seen that when  a  spot mutation in the polypeptide chain affects 
an aaUno  acid with a  low  or high pK,  the total charge variation results  in 
a  change  o£  0.1  pi units per charged residue  substituted (i.e.  per proton 
lost or acquired).  However,  when  the  substitution is on a  His residue  (Hb's 
Malm~and Wood)  or when  the  terminal  -NH2  is chemically modified  (carbamyla-
ted Hb  ),  the ~pi is much  smaller,  since only about  ~and i  of a  proton, 
respectively,  are lost per modified amino  acid residue. As  a  rule  of  thumb 
(for proteins of at least  40  000  daltons and in the case of few  amino  acid 
substitutions) it can be  stated that when  the pK  of a  charged group  lies at 
least  two  pH  units on either side of the pi of  a  protein,  the  "mutant" pro-
tein will change  its pi,  in comparison with  the  "wild type",  of about  0.1 
pH  unit/charged residue  lost or acquired.  Thus  IEF  can be  used not  only to 
separate  genetic variants but  also to predict,  by  pi measurements,  the 
extent  of amino  acid substitution. 
A word  of caution should  be  stated against the indiscriminate use of 
IEF  for  the resolution of any  separation problem.  While it appears that in 
most  cases,  concerning protein separations,  no artefacts are  generated, 
there are entire groups of compounds  which  produce  spectacular artefacts in 
IEF.  Recently  (11  ),  we  have  demonstrated that focusing  of nucleic acids 
(t-RNA)  produces a  series of multiple  bands representing specific complexes 
among  t-RNA  and  the carrier arnpholytes which  generate and stabilize the  pH 
gradient. As  the macromolecule  travels towards its pi  (if any  )  it crosses 
the  boundaries of a  stack of a  multiphasic  buffer  (the focused  arnpholytes) 
thus  generating  the  observed  spectrum of bands.  The  same  happens with acidic 
dyes  (12)  and with heparin  (13).  We  have  demonstrated that this phenomenon 
is also elicited by all polyanions  (polysulphates,  such as heparin,  poly-
phosphates,  such as nucleic acids and polycarboxylates,  such  as polygalactu-
ronic  acid)  (14).  Even  a  protein model,  polyglutarnic acid,  generates  the 
same  artefacts and it can be  anticipated  that polycations  (polylysine, 
polyarginine)  and other very basic compounds,  such as histones and protamine, 
will  behave  in the  same  fashion. 
What  is new  in IEF?  More  than 10  years after its introduction,  new  de-
velopments in IEF  are still far  from  reaching a  plateau.  One  promising de-
velopment,  made  in our department,  is IEF  at very low  temperatures  (-20 to 
-30°  c)  in modified polyacrylamide gels containing anti-freezing solvents 
(dimethylsulphoxide,  ethylene  glycol,  etc.). In this system,  it should be 
possible to detect reaction intermediates,  such as enzyme-substrate com--44-
plexes,  which  dissociate  too  quickly at room  temperature.  Another promising 
variant is "pH  gradient modifier"IEF,  which consists in further flattening 
the pH  gradient in the region of interest in order to optimize the resolu-
tion of closely adjacent protein zones  (15,  16).  This is achieved by  adding 
to the Ampholine  mixture appropriate amphoteric compounds  (usually 50  to 
100  mM)  having a  pi very close to the pi's of the proteins to  be  separated. 
By  this technique,  we  have  been able  to fully separate HbA  from HbAIC'  one 
of  the minor  components  of the  glycosylated Hb  pool,  whose  quantitation is 
important in the .f.oll:)w-up  of diabetic patients. 
As  summarized  in Fig.  1, it would  appear  that there are no  new  electro-
phoretic  techniques in sight,  and  that all the possibilities have  been 
exploited.  Yet,  as indicated by  the  two  dotted lines, it is possible to an-
ticipate the possibility of working diagonally,  by performing  a  sort of 
affino-isotachophoresis or affino-isoelectric focusing.  If a  suitable li-
gand  forming  a  strong complex with a  protein can be  found,  it should  be  pos-
sible to alter the mobility or  the pi of a  protein in such  a  way  that its 
position in the  stack or in the  pH  gradient will  be  removed  from  adjacent 
contaminants  (this principle has  been recently applied in "charge-shift 
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Fig.  1 
Classification of electrophoretic techniques.  The  velocity of the pro-
tein zones is plotted against  the pH  in the·zones.  A:  zone  electrophoresis 
and moving  boundary electrophoresis;  B:  discontinuous  zone  electrophoresis  ; 
C:  isoelectric focusing  (at equilibrium);  D:  isotachophoreris  (modified 
from R.J.  Routs,  Ph.D.  Thesis,  Technical  University of Eindhoven,  The 
Netherlands,  1971). -45-
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